Boulding Mark Elliott's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Feb 19, 2026
- Accession no.
- 0001578852-26-000008
- Filed
- Feb 19, 2026
- Trade date
- Feb 17-18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $408.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boulding Mark ElliottCIK 0001578852 | Officer (EXEC. VP AND CLO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +2,813 | $25.69 | +$72,265.97 | 114,125 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −2,811 | $69.29F2 | −$194,774.19 | 111,314 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −2 | $70.13 | −$140.26 | 111,312 | Direct | |
| Feb 18, 2026 | Common Stock | SSaleDisposed | −3,081 | $69.36 | −$213,698.16 | 108,231 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −2,813 | $0.00 | $0 | 22,501 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.84 to $69.80 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.